Navigation Links
Downtown Dermatology Informs Columbus Community About Melasma
Date:9/3/2013

Columbus, OH (PRWEB) September 03, 2013

Melasma is a common skin condition that is characterized by patchy brown or gray-brownish discoloration on the face or other areas of the body that are exposed to a lot of sun. When color-making cells in the skin called, melanocytes, become over-stimulated, they can generate an excessive amount of pigmentation, which results in areas of discoloration. The condition occurs most often in women between the ages of 20 and 50 of Latin/Hispanic, North African, African-American, Asian, Indian, Middle Eastern, and Mediterranean descent, or those with olive or darker skin tones because these darker tones contain more melanocytes.

Symptoms
The only symptom of melasma is skin discoloration, however, individuals with this skin condition can often experience stress or anxiety as a result of the change in their physical appearance.

Discoloration most commonly appears on the:

  •      Cheeks
  •     Bridge of nose
  •     Forehead
  •     Chin
  •     Upper Lip
  •     Forearms
  •     Neck

Nearly 50 million women worldwide have experienced melasma, which accounts for about 90 percent of all cases. Melasma is also more prevalent in pregnant women and has even earned itself a pseudo name, “the mask of pregnancy.” While not nearly as common, men can develop this skin condition as well.

Cause
The exact cause of melasma is not entirely clear. One of the contributing factors could be a change in hormones due to pregnancy, birth control or hormone replacement medications. The sun is also a huge contributor to melasma because ultraviolet light stimulates melanocytes, which leads to pigment overproduction. Certain skin care products have also been known to irritate the skin and increase melasma symptoms.

Treatment
Melasma typically fades over time without medical intervention. For those who have symptoms that will not go away or chronically reappear, there are several treatment options available, usually in the form of an over-the-counter or prescription strength cream that works to lighten skin tone.

Prevention
Sun protection is the number one piece of preventative advice for individuals who are concerned about melasma. Sunscreen should be applied every day at least 20 minutes prior to sun exposure. Your sunscreen should be formulated to protect against UVA and UVB rays with an SPF of at least 30. And remember, sunscreen isn't permanent, so reapply every couple hours. Wearing protective clothing like wide brimmed hats to shade the face and neck or long sleeves and pants can also help to ward off the on-set of melasma symptoms.

If you are experiencing symptoms of melasma or would like to find out more about this skin condition, treatment and prevention, contact Downtown Dermatology at http://columbusdowntownderm.com or call 614-224-4566. Downtown Dermatology is conveniently located in the Market Exchange district at 500 East Main Street, Columbus, Ohio.

Read the full story at http://www.prweb.com/releases/Melasma/skin-discoloration/prweb11083396.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Yumi Media Released a Statement Regarding Ella Dining Room and Bar Offering an All-Vegetarian Menu for Dine Downtown This Year
2. Flightlinez Las Vegas Located Downtown - OPEN and Zipping During Construction
3. Dwell Media and ASID Team up with Klein Financial to Reinvigorate Downtown LA Lofts
4. Foundations Recovery Network Opens Outpatient Treatment Facility in Downtown Nashville
5. Canadian Tourism College Moving to New Downtown Campus
6. Study paints complex health portrait of single-room occupancy hotel tenants in Downtown Eastside
7. Aesthetic Dermatology Specialty Centre Gets A Facelift
8. Southlake Dermatology Offers New Pliaglis Anesthetic Cream
9. Water’s Edge Dermatology Opens Vero Beach Clinic- Sixth Treasure Coast Location
10. Urban Dermatology Turns to Palomar Medical Technologies for its Vectus Hair Removal Laser Tool
11. Dermatology Alliance-Keller Offers Reveal Facial Imager
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... miniature, folded, pharmaceutical inserts and outserts. As a means of expanding capabilities ... addition will enable Flottman to individually code professional inserts (PIs) and patient package ...
(Date:12/9/2016)... NY (PRWEB) , ... December 09, 2016 , ... ... and Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits ... and the District of Columbia as an education tool in the war against teen ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted ... all types of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves ... use and could be set up in a matter of minutes, or even seconds. ...
(Date:12/9/2016)... ... 09, 2016 , ... The Holy Name Medical Center Foundation ... on December 3rd, to benefit Holy Name Medical Center's programs and services. More ... over $1 million - the largest event in the Center's history, both in ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying to get ... thought that if the nebulizer had a more child-friendly design, then children would be ... developed the patent-pending NEBY to avoid the need to deliver medication via a nebulizer ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... -- Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices Market Outlook to 2022", provides ... Devices market. The report provides value, in millions ... prices (USD) within market segement - Glaucoma Drainage ... and distribution shares data for each of these ...
(Date:12/8/2016)... 2016 KEY FINDINGS The global ... 2017-2023. Various reasons for growth of the medical lifting ... of chronic diseases, high recovery cost of injuries and ... Medical lifting sling refers to an assistive device that ... slings connect to the lift and hold the patient. ...
(Date:12/8/2016)... Lilly and Company (NYSE: LLY ) today ... at the 9 th Clinical Trials on Alzheimer,s ... meet the primary endpoint in the EXPEDITION3 clinical trial, ... dementia due to Alzheimer,s disease (AD), and Lilly will ... of mild dementia due to AD. ...
Breaking Medicine Technology: